BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 27052803)

  • 21. Pea early-browning virus-mediated genome editing via the CRISPR/Cas9 system in Nicotiana benthamiana and Arabidopsis.
    Ali Z; Eid A; Ali S; Mahfouz MM
    Virus Res; 2018 Jan; 244():333-337. PubMed ID: 29051052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome editing via delivery of Cas9 ribonucleoprotein.
    DeWitt MA; Corn JE; Carroll D
    Methods; 2017 May; 121-122():9-15. PubMed ID: 28410976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome scale screening identification of SaCas9/gRNAs for targeting HIV-1 provirus and suppression of HIV-1 infection.
    Wang Q; Liu S; Liu Z; Ke Z; Li C; Yu X; Chen S; Guo D
    Virus Res; 2018 May; 250():21-30. PubMed ID: 29625148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Method for Dual Viral Vector Mediated CRISPR-Cas9 Gene Disruption in Primary Human Endothelial Cells.
    Gong H; Liu M; Klomp J; Merrill BJ; Rehman J; Malik AB
    Sci Rep; 2017 Feb; 7():42127. PubMed ID: 28198371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of an Inducible CRISPR/Cas9 System for CXCR4 Gene and Demonstration of its Effects on MKN-45 Cells.
    Peng Y; Yang T; Tang X; Chen F; Wang S
    Cell Biochem Biophys; 2020 Mar; 78(1):23-30. PubMed ID: 31875277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas9 Based Genome Editing of Penicillium chrysogenum.
    Pohl C; Kiel JA; Driessen AJ; Bovenberg RA; Nygård Y
    ACS Synth Biol; 2016 Jul; 5(7):754-64. PubMed ID: 27072635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology.
    Qiu Y; Ding Q
    STAR Protoc; 2021 Mar; 2(1):100307. PubMed ID: 33554142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of the CRISPR-Cas9 effector complex assembly and the role of 3'-terminal segment of guide RNA.
    Mekler V; Minakhin L; Semenova E; Kuznedelov K; Severinov K
    Nucleic Acids Res; 2016 Apr; 44(6):2837-45. PubMed ID: 26945042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas9-mediated gene knockout is insensitive to target copy number but is dependent on guide RNA potency and Cas9/sgRNA threshold expression level.
    Yuen G; Khan FJ; Gao S; Stommel JM; Batchelor E; Wu X; Luo J
    Nucleic Acids Res; 2017 Nov; 45(20):12039-12053. PubMed ID: 29036671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing.
    Kaminski R; Chen Y; Fischer T; Tedaldi E; Napoli A; Zhang Y; Karn J; Hu W; Khalili K
    Sci Rep; 2016 Mar; 6():22555. PubMed ID: 26939770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting human cytomegalovirus IE genes by CRISPR/Cas9 nuclease effectively inhibits viral replication and reactivation.
    Xiao J; Deng J; Zhang Q; Ma P; Lv L; Zhang Y; Li C; Zhang Y
    Arch Virol; 2020 Aug; 165(8):1827-1835. PubMed ID: 32507978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guide RNA engineering for versatile Cas9 functionality.
    Nowak CM; Lawson S; Zerez M; Bleris L
    Nucleic Acids Res; 2016 Nov; 44(20):9555-9564. PubMed ID: 27733506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Era of CRISPR/ Cas9 Mediated Plant Genome Editing.
    Khurshid H; Jan SA; Shinwari ZK; Jamal M; Shah SH
    Curr Issues Mol Biol; 2018; 26():47-54. PubMed ID: 28879855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
    Najah S; Saulnier C; Pernodet JL; Bury-Moné S
    BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Points of View on the Tools for Genome/Gene Editing.
    Chuang CK; Lin WM
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.
    Wang Z; Wang W; Cui YC; Pan Q; Zhu W; Gendron P; Guo F; Cen S; Witcher M; Liang C
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of highly efficient sgRNAs for CRISPR/Cas9-based plant genome editing.
    Liang G; Zhang H; Lou D; Yu D
    Sci Rep; 2016 Feb; 6():21451. PubMed ID: 26891616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.